COSA 2014*
Chair: Sandro Porceddu
Sponsored by:
The changing nature of Stage 4 cancer (#1)
9:00 AM
The utility and limitations of imaging oligometastatic disease (#2)
9:10 AM
Tailoring systemic treatments for metastatic disease (#3)
9:25 AM
Role of Radiotherapy for Oligometastases (#4)
9:45 AM
Treatment of metastatic lung cancer: The ESMO Clinical Benefit Scale (ESMO CBS) (#5)
10:05 AM